Schedule Demo

Transpara® Detection

The gold standard in AI breast cancer detection

Backed by dozens of clinical studies, including the only randomized controlled trial in Breast AI, Transpara Detection’s
concurrent reading workflow helps radiologists streamline reviews, prioritize high risk cases, and detect more cancer, earlier.

one_1 (1)

The leading Breast AI

in scientific papers and conference presentations
The leading Breast AI
mammos_3 (1)

10 million+ mammograms

processed by Transpara Detection
10 million+ mammograms
cleared_3 (1)

FDA-cleared, CE-marked

for 3D/DBT and 2D/FFDM
FDA-cleared, CE-marked
world_2 (1)

30+ countries

implemented and in use worldwide
30+ countries

Reduce time spent reviewing exams marked as Low (L) Risk (70% of screening studies or more) by up to 26% overall. Low Risk studies boast a 99.97% NPV (Negative Predictive Value).

The Transpara Report

Actionable information at a glance
 
Transpara solutions work together to provide a clear, concise, and accurate assessment of each exam (your ‘second pair’ of eyes), helping you focus on the highest risk cases and triage patients toward the most appropriate supplemental screening modalities.
 
Importantly, the algorithm's performance is strong when it matters most: Transpara Detection is accurate and robust regardless of a woman's ethnicity, age, BMI, and breast density.
Motion template_v1
Note: brackets in pink added for effect and are not part of device
Transpara has High Impact in Low Risk Studies

Enhance Your Workflow

AI-driven risk stratification

Transpara Detection categorizes exams based on their risk of breast cancer being present using three categories of risk - Elevated, Intermediate, Low -, alongside Region Risk marks which highlight areas of suspicion.

Unique to Transpara Detection, Low Risk category cases are unmarked for expedited review, with an NPV of 99.97% underscoring your confidence to quickly review these exams.

Seamless and adaptable integration
Routine algorithmic performance updates
Support from our team of experts

Trusted by organizations and women across the globe

With installations in 30+ countries and 10 million+ mammograms assessed worldwide, Transpara Detection is the solution of choice for screening and diagnostics at a practice and population level.

 

Transpara Breast AI is installed across the United States of AmericaLeading hospitals, radiology practices, imaging centers, and health systems rely on Transpara to drive value for their patients, their providers, and their practices. 

With a presence from coast to coast, ScreenPoint Medical works with the premier healthcare organizations in the United States to create a new standard for workflow efficiency, population health impact, and breast cancer detection.

Research from UCLA suggests Transpara could reduce interval cancers by 30%.

Transpara Detection in use across Europe 2025

Transpara is in use in screening and diagnostic settings across Europe, and notably, the landmark MASAI randomized controlled trial in Sweden found a 44% reduction in workload and a 29% increase in cancer detection when adopting Transpara Detection across a study of over 100,000 women.

Additional large-scale studies from Denmark, Norway, Turkey, and Spain attest to the global impact of Transpara.

Transpara in use worldwide 2025Transpara Detection has been successfully deployed in over 30 countries across the globe.

As a global organization, ScreenPoint Medical has analyzed over 10 million mammograms from women around the world, a number that continues to grow. With Transpara, trust is the most essential part of the equation.

Integrates seamlessly within your workflow

The results from Transpara Detection are available via the systems and platforms you use today.

Want to learn more? Schedule a demo with our team of experts today.
Want to learn more? Schedule a demo with our team of experts today.

Explore additional Transpara® solutions

Transpara® Density

Transpara® Density

Transpara Density combines a BI-RADS-like assessment as well as volumetric breast density for consistency in analysis and reporting.

Go →
Transpara® Temporal Comparison

Transpara® Temporal Comparison

The power of priors in action: track findings across up to three prior mammograms (if available), from 9 months to 6.5 years prior.

Go →
Schedule Demo